Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...
SALT LAKE CITY, Nov. 7, 2025 /PRNewswire/ -- Resonant, a Renew Biotechnologies subsidiary developing novel diagnostic tools for neurodegenerative diseases, announces the receipt of "DNA Sequencing ...
CORONA, Calif., Nov. 10, 2025 /PRNewswire/ -- The DNA Company, a global leader in functional genomics and personalized health, has been named Functional Genomics Innovation of the Year in the 2025 ...
This image compares three DNA sequencing technologies: Sanger sequencing, Massively Parallel DNA sequencing, and Nanopore DNA sequencing. Sanger sequencing (left) sequences 500-700 bases per reaction ...
The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and ...
A new Seattle biotech organization will be funded to the tune of $75 million to research “DNA typewriters,” self-monitoring cells that could upend our understanding of biology. The collaboration ...
A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and efficiently read DNA containing non-standard bases — a task once thought too ...
The 2025 MM+M Agency 100 honoree debuted DNAHelix in a bid to help biotech companies develop a unified brand narrative and engage with key stakeholders as they grow. The launch of DNAHelix also ...
Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results